GSK sacks 110 China staff in wake of drug bribery case: sources
Drugmaker GlaxoSmithKline (GSK.L), which was fined 3 billion yuan ($479 million) in China last year for bribery, is dismissing 110 employees in the country for misconduct, people familiar with the matter said on Friday.